Skip to main content
SpringerLink
Log in

Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients

  • Letter
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Moore CK, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ (2012) Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case–control study. Clin Infect Dis 54:51–58

    Article  CAS  PubMed  Google Scholar 

  2. Bassetti M, Nicco E, Ginocchio F, Ansaldi F, de Florentiis D, Viscoli C (2010) High-dose daptomycin in documented Staphylococcus aureus infections. Int J Antimicrob Agents 36:459–461

    Article  CAS  PubMed  Google Scholar 

  3. Falcone M, Russo A, Venditti M, Novelli A, Pai MP (2013) Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 57(11):1568–1576

    Article  CAS  PubMed  Google Scholar 

  4. Sharma M, Riederer K, Chase P, Khatib R (2008) High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 27:433–437

    Article  CAS  PubMed  Google Scholar 

  5. Moise PA, North D, Steenbergen JN, Sakoulas G (2009) Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions. Lancet Infect Dis 9:617–624

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The work was carried out as part of the regular work of the hospital and university departments.

Conflicts of interest

MB, FP, CT, FGDR and FM have received funding for travel or speaker honoraria from Novartis. The other authors declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Infectious Diseases Division, Santa Maria Misericordia University Hospital, Piazzale Santa Maria della Misericordia 30, 33100, Udine, Italy

    Matteo Bassetti, Giovanni Villa, Elda Righi & Massimo Crapis

  2. Department of Health Sciences, IRCCS San Martino IST, University of Genoa, Genoa, Italy

    Filippo Ansaldi & Daniela De Florentiis

  3. Infectious Diseases Unit, Nuovo Ospedale Santa Chiara, Pisa, Italy

    Carlo Tascini & Francesco Menichetti

  4. Institute of Clinical Pharmacology, Azienda Ospedaliero–Santa Maria Misericordia University Hospital, Udine, Italy

    Piergiogio Cojutti & Federico Pea

  5. Microbiology Unit, Santa Maria Misericordia University Hospital, Udine, Italy

    Assunta Sartor

  6. Department of Medical Sciences, University of Turin, Turin, Italy

    Francesco Giuseppe De Rosa

  7. Department of Infectious Diseases, Amedeo di Savoia Hospital, Turin, Italy

    Francesco Giuseppe De Rosa

Authors
  1. Matteo Bassetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanni Villa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Filippo Ansaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniela De Florentiis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carlo Tascini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Piergiogio Cojutti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Elda Righi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Assunta Sartor
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Massimo Crapis
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Francesco Giuseppe De Rosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Federico Pea
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Francesco Menichetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matteo Bassetti.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bassetti, M., Villa, G., Ansaldi, F. et al. Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients. Intensive Care Med 41, 366–368 (2015). https://doi.org/10.1007/s00134-014-3571-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-014-3571-6

Keywords

Search

Navigation